Mitoxantrone and endocardial fibrosis Patient Reports February 13, 2012

Mitoxantrone Side Effects Report #5427706-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from GERMANY on Aug 15, 2007. Male patient, 58 years of age, was diagnosed with encephalitis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. Mitoxantrone dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5382147-9
Mitoxantrone side effect was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. Mitoxantrone dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5388462-7
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Female patient was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. Mitoxantrone dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.